Nedra Harrington
Acute Care · Potosi, MONPI 1386805786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by AbbVie at 38.3% of the total. Reporting peaked in 2023 at $2,481 and has fallen 63.7% since, to $900 in 2025. Among acute care clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novo Nordisk$396
- Amgen$389
- Johnson & Johnson$316
- Organon$277
- Boehringer Ingelheim$260
- plus $3K from 37 others
What the payments were for
- Food & beverage$8,129100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,140 in reported general payments places this provider in the 95th percentile of 272 acute care providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $52,528 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $50,166 |
| MounjaroTirzepatide | 24 | $42,395 |
| JardianceEmpagliflozin | 59 | $41,412 |
| FarxigaDapagliflozin Propanediol | 18 | $20,295 |
| EliquisApixaban | 13 | $20,151 |
| Repatha SureclickEvolocumab | 17 | $11,239 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $10,921 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $10,665 |
| LinzessLinaclotide | 15 | $10,529 |
| XareltoRivaroxaban | 11 | $9,813 |
| JanuviaSitagliptin Phosphate | 14 | $7,567 |
| Spiriva RespimatTiotropium Bromide | 11 | $7,074 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 114 | $3,004 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $2,625 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $396 | $52,52850 claims |
| GSKTrelegy Ellipta | $183 | $50,16647 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $260 | $48,48570 claims |
| Lilly USA, LLCMounjaro | $245 | $42,39524 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $222 | $30,96031 claims |
| PfizerEliquis | $16 | $20,15113 claims |
| AbbVieLinzess, Synthroid | $3,120 | $11,46935 claims |
| Johnson & JohnsonXarelto | $316 | $9,81311 claims |
| MerckJanuvia | $63 | $7,56714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 272 acute care providers in Missouri.
Other acute care in Potosi
- Molly CahillKansas City$22K
- Kristin PressChesterfield$14K
- Sarah HeaveyKansas City$9K
- Hunter SmithColumbia$7K
- Heather UelhofO Fallon$6K
- Caroline MundhenkeKansas City$6K
- Jennifer ReganSaint Louis$5K
- Jena SchollCape Girardeau$5K
- Kayla TourvilleSaint Louis$5K
- Christa SinkSaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.